Fidelity Investments
TAK icon

Fidelity Investments’s Takeda Pharmaceutical TAK Stock Holding History

Fidelity Investments’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$154M Buy
9,599,302
+2,481,816
+35% +$41.1M 0.01% 1040
2026
Q1 		$132M Buy
7,117,486
+3,060,618
+75% +$53.7M 0.01% 1049
2025
Q4 		$63.2M Sell
4,056,868
-130,078
-3% -$1.86M ﹤0.01% 1345
2025
Q3 		$61.3M Buy
4,186,946
+85,285
+2% +$1.27M ﹤0.01% 1370
2025
Q2 		$63.4M Buy
4,101,661
+236,563
+6% +$3.5M ﹤0.01% 1299
2025
Q1 		$57.5M Buy
3,865,098
+478,810
+14% +$6.71M ﹤0.01% 1302
2024
Q4 		$44.8M Buy
3,386,288
+477,370
+16% +$6.56M ﹤0.01% 1424
2024
Q3 		$41.4M Buy
2,908,918
+286,052
+11% +$4.06M ﹤0.01% 1454
2024
Q2 		$33.9M Buy
2,622,866
+48,626
+2% +$644K ﹤0.01% 1464
2024
Q1 		$35.8M Buy
2,574,240
+395,850
+18% +$5.76M ﹤0.01% 1455
2023
Q4 		$31.1M Sell
2,178,390
-414,960
-16% -$5.89M ﹤0.01% 1471
2023
Q3 		$40.1M Buy
2,593,350
+115,947
+5% +$1.79M ﹤0.01% 1326
2023
Q2 		$38.9M Sell
2,477,403
-15,618
-0.6% -$256K ﹤0.01% 1366
2023
Q1 		$41.1M Buy
2,493,021
+189,141
+8% +$3.01M ﹤0.01% 1330
2022
Q4 		$35.9M Buy
2,303,880
+293,970
+15% +$4.11M ﹤0.01% 1391
2022
Q3 		$26.1M Buy
2,009,910
+155,918
+8% +$2.17M ﹤0.01% 1520
2022
Q2 		$26M Sell
1,853,992
-594,212
-24% -$8.48M ﹤0.01% 1546
2022
Q1 		$35.1M Buy
2,448,204
+525,999
+27% +$7.72M ﹤0.01% 1546
2021
Q4 		$26.2M Buy
1,922,205
+144,880
+8% +$2.03M ﹤0.01% 1695
2021
Q3 		$29.1M Buy
1,777,325
+219,185
+14% +$3.68M ﹤0.01% 1663
2021
Q2 		$26.2M Buy
1,558,140
+271,764
+21% +$4.63M ﹤0.01% 1727
2021
Q1 		$23.5M Buy
1,286,376
+330,353
+35% +$5.94M ﹤0.01% 1738
2020
Q4 		$17.4M Buy
956,023
+10,129
+1% +$178K ﹤0.01% 1772
2020
Q3 		$16.9M Sell
945,894
-42,592
-4% -$776K ﹤0.01% 1633
2020
Q2 		$17.7M Buy
988,486
+104,692
+12% +$1.88M ﹤0.01% 1600
2020
Q1 		$13.4M Buy
883,794
+328,184
+59% +$5.95M ﹤0.01% 1584
2019
Q4 		$11M Sell
555,610
-49,384
-8% -$945K ﹤0.01% 1813
2019
Q3 		$10.4M Sell
604,994
-2,103,312
-78% -$36.4M ﹤0.01% 1811
2019
Q2 		$47.9M Sell
2,708,306
-4,854,953
-64% -$88.3M 0.01% 1239
2019
Q1 		$154M Buy
7,563,259
+7,563,179
+9,453,974% +$152M 0.02% 737
2018
Q4 		$1K Buy
+80
New +$1.35K ﹤0.01% 3425

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Fidelity Investments's TAK Position: Q2 2026 in Review

Fidelity Investments increased its Takeda Pharmaceutical (TAK) stake by 35% in Q2 2026, buying an estimated $41.1M and bringing the position to 9,599,302 shares worth $154M. The position accounts for 0.01% of the portfolio, ranked #1040.

Fidelity Investments first reported a position in TAK in Q4 2018 and has held it in 31 quarters since. The position peaked at $154M in Q1 2019. 378 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Fidelity Investments held 9,599,302 shares of Takeda Pharmaceutical worth $154M as of Q2 2026.
  • Fidelity Investments bought 2,481,816 Takeda Pharmaceutical shares in Q2 2026, an estimated $41.1M.
  • Takeda Pharmaceutical made up 0.01% of Fidelity Investments's portfolio in Q2 2026, its #1040 holding.
  • Fidelity Investments first reported a position in Takeda Pharmaceutical in Q4 2018 and has held it in 31 quarters since.
  • Fidelity Investments's Takeda Pharmaceutical position peaked at $154M in Q1 2019.
  • 378 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.